2016
DOI: 10.1586/14760584.2016.1167602
|View full text |Cite
|
Sign up to set email alerts
|

Maternal and neonatal pneumococcal vaccination - where are we now?

Abstract: Pneumococcus is a significant pathogen in neonates and in early infancy, particularly as a cause of invasive disease in sub-Saharan Africa where nasopharyngeal carriage rates are also exceptionally high. The pneumococcal-conjugate vaccines have now been rolled out in many high income settings and an increasing number of low and middle income countries. They have been highly effective at preventing vaccine serotype disease in infants. However, a window of susceptibility remains prior to the first vaccination at… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
14
2

Year Published

2017
2017
2022
2022

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 16 publications
(16 citation statements)
references
References 50 publications
(73 reference statements)
0
14
2
Order By: Relevance
“…Group B streptococcus and S pneumoniae present specific opportunities for interventions, for example by maternal immunisation. [141][142][143] Our results show sub-regional geographical variation in the distribution of specific bacterial pathogens between and within regions (table 2). One key finding was the higher number of studies from southern Africa reporting group B streptococcus infections compared with other regions, although the prevalence of infections did not differ significantly across regions.…”
Section: Discussionmentioning
confidence: 58%
“…Group B streptococcus and S pneumoniae present specific opportunities for interventions, for example by maternal immunisation. [141][142][143] Our results show sub-regional geographical variation in the distribution of specific bacterial pathogens between and within regions (table 2). One key finding was the higher number of studies from southern Africa reporting group B streptococcus infections compared with other regions, although the prevalence of infections did not differ significantly across regions.…”
Section: Discussionmentioning
confidence: 58%
“…The primary goal of this study was not to test protection via maternal immunity or immunization—a topic that has been the focus of much clinical investigation (reviewed in reference 21). Pneumococcal carriage is common by 2 months of age in the developing world and, in some locations, this pathogen is second only to group B Streptococcus as a cause of invasive bacterial infection in infants (22).…”
Section: Discussionmentioning
confidence: 99%
“…Adequate passive transfer of Ig through colostrum is essential for the survival of the equine neonate, and a valuable strategy against pathogens that challenge the species in early age. Nevertheless, questions remain about the mechanisms by which circulating maternally-derived antibodies affect the development of the neonate’s endogenous humoral immunity, and the overall impact on vaccination response later in life has yet to be defined [57,58]. Other aspects that affect directly and indirectly humoral responses in neonates involve antigen presenting cell competence to activate T cells, co-stimulatory capacity of T cells to stimulate B cells and, importantly, quality of vaccine, including immunogenicity and recognition by different toll-like receptors [59].…”
Section: Discussionmentioning
confidence: 99%